SS-31 2S10 2S50 MT1 ML10 OT2 RA10 P41 BBG70 KLOW80 WA3 WA10 BA3 BA10 The best price
TDS 35 Inquiries
129954-34-3
Pharmaceutical Grade
99%
shenzhen
SC
10 mg / 15mg/ 20 mg / 30 mg / 10 tubes per box
2027-03-17
tr
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceSelank is a synthetic derivative of the tetrapeptide tuftsin that contains a proline-glycine-proline sequence at the C-terminus and has anxiolytic and anti-inflammatory activities. It increases the amplitude and discharge rate of inhibitory postsynaptic currents of neurons in the rat hippocampal CA1 region when used at a concentration of 1 μM. It decreases the level of affective responses and the number of erroneous escape attempts in rats in an acute stress situation, increases orientational-investigative responses of rats in an unfamiliar situation, and reduces the time mice spend immobile in the forced swim test. It increases locomotor activity of high-anxiety Balb/c, but not C57Bl/6, mice in the open field test. Selank (0.01 mg/kg) decreases verticalization induced by apomorphine in mice. It also decreases expression of the inflammation-related genesIl2rgandXcr1in mouse spleen after 90 minutes when administered at a dose of 100 μg/kg.
SELANK Synthetic is a single, non-glycosylated polypeptide chain containing 7 amino acids, having a molecular mass of 751.89 Dalton and a Molecular formula of C33H57N11O9.Certificates-
TDS
Basic Info-
Product Name:
Selank peptide
Other Name:Selank peptide;SelankAcetate;PL14736;L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-L-proline;L-THREONYL-L-LYSYL-L-PROLYL-L-ARGINYL-L-PROLYLGLYCYL-L-PROLINE; MONOACETATE;H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH;SLANK;Selank peptid
CAS No.:129954-34-3
Molecular Formula:C33H57N11O9
InChIKeys:JTDTXGMXNXBGBZ-YVHUGQOKSA-N
Molecular Weight:751.87
Exact Mass:751.43407244
EC Number:232-660-2
UNII:TS9JR8EP1G
Categories:
Characteristics-
Density:
1.53±0.1 g/cm3(Predicted)
Melting Point:134-136 °C
PKA:3.43±0.20(Predicted)
Research-
Class:
Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)
Status:FDA-approved (Forzinity) — Accelerated Approval 2025
Mechanism:A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.
Activity note:SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.
Source:Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI
Clinical Development:FDA:Forzinity (approved 2025-09-19)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
FDA: Forzinity (NDA 215244) — Accelerated Approval 2025; Genetics in Medicine: TAZPOWER Phase 2/3 results (Thompson et al. 2020); Drugs: Elamipretide First Approval (Springer 2025)
Disclaimer:Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
tr
-
Location:
B27 SHING LEE COMM BLDG 8WING KUT ST CENTRAL HONGKONG
-
Average lead Time:
1 days
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History35 Inquiries
Country Product Purchase Quantity Date Posted
United States
Selank 99% Purity 129954-34-3
1 G Jan 23, 2026
Greece
selank
10 MG May 20, 2026
United States
N acetyl selank
500 MG Apr 30, 2026
United States
Selank
100 MG Apr 24, 2026
Italy
Nacetyl selank
1 MT Apr 22, 2026
Oman
Selank
1 G Mar 4, 2026
United States
Selank
30 40' Fcl Oct 14, 2025
United States
selank
100 MG Jul 7, 2026
Netherlands
Selank
10 MT Jun 22, 2026
Netherlands
Selank 20 mg
20 MT Jun 8, 2026
Australia
selank
3 MT Mar 8, 2026
France
Selank
10 MT Feb 28, 2026
Nigeria
retatutride 5mg 10mg 15mg 20mg
100 MG Feb 24, 2026
Canada
FST 344
1 MT Nov 18, 2025
United States
Selank
10 MG Nov 5, 2025
United States
selank
10 MG Nov 3, 2025
United States
Selank
1 G Apr 2, 2025
Norway
98% N-Acetyl Selank Amidate
250 G Dec 17, 2024
Canada
Youngshe 98% Selank N-Acetyl Selank Amidate N-Acetyl Selank
60 G Oct 16, 2024
United States
Selank
20 MT Jan 27, 2024 Post an enquiry for this product
More from this Seller
-
-
-
NP810 XA5 XA10 SK5 CAS1415456-99-3 Recombinant peptide Factory quotation
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
P41 XT100 GT1500 AP5 RT50 TR50 SuperHumanBlend MT-2(Melano 2Acetate) BC20 Snap-8 KS5
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
Safe delivery of personalized peptides SHB SK10 SK5 SLU-PP-322 SM10 SM15 SM2 SM20
Cosmetics Grade / 99%
$1/G FOB
-
-
-
-
BAC water cagrilintide 2.5mg+Samaglutide2.5mg cagrilintide 5mg+Samaglutide5mg
Pharmaceutical Grade / 99%
$1/G FOB
-